Reynolds Mark

Avg. Two Year Performance

(40%) Avg. Purchase Return
(18%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(21%)(31%)(45%)(40%)
Purchase Success Rate0 of 41 of 42 of 41 of 41 of 4
Average Sale Return----------
Sale Success Rate----------
Other » Other

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CFO:

Holdings: 7.21K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--